MedPath

A multicenter, cooperative prospective, nonrandomized, open-label, comparative study using historical controls to verify the effectiveness of simple plasma exchange therapy for patients with the most severe form ANCA associated vasculitis

Not Applicable
Conditions
ANCA associated vasculitis
Registration Number
JPRN-UMIN000031999
Lead Sponsor
Juntendo university
Brief Summary

The 52-week survival rate of patients in the PE group (n = 4) was higher than that of the historical control group (n = 16) (100% vs. 13%, p = 0.04).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
4
Inclusion Criteria

Not provided

Exclusion Criteria

If there is a withdrawal of consent of research cooperation from the research subject. When the whole research is canceled. If for other reasons the researcher judges that the cancellation of research is appropriate. When adverse reactions with difficult plasma continuation therapy appear.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
One year survival rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath